ArticleInternational journal of molecular and cellular medicine2019

Inhibitor of Interleukin-1 Receptor-associated Kinases 1/4, Can Increase the Sensitivity of Breast Cancer Cells to Methotrexate.

Samaneh Rahemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.